Wildlife Disease Diagnostics: Sample Collection, Preservation, and Laboratory Testing

Wildlife disease diagnostics requires standardized methods for collecting, preserving, and testing samples from free-ranging and captive animals to detect pathogens, monitor disease trends, and inform management decisions. Wildlife veterinarians, diagnostic laboratory staff, and disease ecologists face unique challenges including variable sample quality, species-specific assay limitations, and logistical constraints in field settings. This article provides practical guidance on sample types, preservation techniques, shipping requirements, and laboratory tests for common wildlife pathogens, with clear limitations and professional escalation criteria.

At a Glance: Wildlife Disease Diagnostic Workflow

The table below summarizes key steps, sample types, and considerations for wildlife disease diagnostics.

Sample Collection Methods for Wildlife

Blood Collection

Blood is a primary sample for serology, hematology, biochemistry, and pathogen detection. Collection methods depend on species size, accessibility, and whether the animal is alive or dead.

For live mammals, blood can be collected from the jugular vein, cephalic vein, saphenous vein, or medial metatarsal vein. In birds, the jugular vein, brachial vein, or medial metatarsal vein are common sites. In reptiles, the ventral coccygeal vein or cardiac puncture under anesthesia may be used. In amphibians, the ventral abdominal vein or cardiac puncture is possible.

For dead animals, blood can be collected from the heart, major vessels, or body cavity within hours of death. Blood from carcasses may be hemolyzed or contaminated, limiting its use for some tests. Document sample quality and note any abnormalities.

Use sterile needles and syringes for each animal. Collect blood into appropriate tubes: plain tubes for serum, EDTA tubes for hematology and PCR, heparin tubes for biochemistry, and citrate tubes for coagulation studies. Fill tubes to the correct volume to maintain proper blood-to-additive ratios.

Record the collection site, time, and any observed abnormalities. Label tubes with the animal's unique identification number, species, date, and collector initials.

Swab Collection

Swabs are used to collect samples from mucosal surfaces for pathogen detection by culture, PCR, or antigen testing. Common swab types include nasal, oral, rectal, conjunctival, and cloacal swabs.

Use sterile synthetic swabs with plastic shafts. Cotton swabs with wooden shafts may inhibit PCR and are not recommended for molecular testing. Place swabs in viral transport media, bacterial transport media, or sterile saline depending on the test requested.

For nasal swabs, insert the swab into the nostril parallel to the palate and rotate gently. For oral swabs, swab the buccal mucosa, tonsillar crypts, and pharynx. For rectal swabs, insert the swab 2 to 4 cm into the rectum and rotate. For conjunctival swabs, gently swab the lower conjunctival sac.

Label each swab container with the animal ID, swab site, date, and time. Keep swabs cool at 4°C and transport to the laboratory within 24 to 48 hours. For long-term storage, freeze at -80°C.

Tissue Collection

Tissue samples are essential for histopathology, immunohistochemistry, PCR, and culture. Collect tissues during necropsy or biopsy procedures.

For necropsy, collect samples from all major organs: brain, lung, heart, liver, spleen, kidney, lymph nodes, gastrointestinal tract, reproductive tract, and any lesions. Collect both fresh and fixed samples.

For fresh samples, place 1 to 2 cm³ pieces in sterile containers and refrigerate or freeze. For PCR, freeze at -20°C or -80°C. For bacterial culture, keep refrigerated and transport within 24 hours. For viral culture, place in viral transport media and freeze at -80°C.

For fixed samples, place 1 to 2 cm³ pieces in 10% neutral buffered formalin at a ratio of at least 10:1 formalin to tissue. Ensure formalin penetrates all tissue surfaces. For large organs, slice to allow penetration. Fixed tissues can be stored at room temperature for months.

Label containers with animal ID, organ, date, and fixative type. Record gross findings, lesion descriptions, and sample locations.

Fecal and Urine Collection

Fecal samples are used for parasitology, bacteriology, and pathogen detection by PCR. Collect fresh feces from the ground, enclosure, or directly from the rectum. Use sterile containers and avoid contamination with soil or water.

For parasitology, collect at least 5 to 10 grams of feces. For bacterial culture, collect at least 1 to 2 grams and place in transport media. For PCR, collect 0.5 to 1 gram and freeze at -20°C or -80°C.

Urine samples are used for urinalysis, culture, and pathogen detection. Collect by free catch, cystocentesis, or catheterization. Use sterile containers and refrigerate if testing within 24 hours. For long-term storage, freeze at -20°C.

Hair, Feather, and Skin Samples

Hair, feathers, and skin samples are used for genetic analysis, toxicology, and ectoparasite detection. Collect hair or feathers by plucking or clipping. For skin, collect biopsy samples or scrape lesions.

Place samples in paper envelopes or sterile containers. For genetic analysis, freeze at -20°C or store in ethanol. For toxicology, use metal-free containers to avoid contamination.

Sample Preservation and Storage

Temperature Control

Proper temperature control is critical for preserving sample integrity. Most samples should be kept cool at 4°C during transport and short-term storage. Freezing at -20°C is suitable for PCR samples and some serology samples. Freezing at -80°C is required for viral culture, RNA preservation, and long-term storage.

Avoid repeated freeze-thaw cycles, which degrade nucleic acids and proteins. Divide samples into aliquots before freezing. Use cryovials or sterile tubes with secure caps.

Fixatives

For histopathology, 10% neutral buffered formalin is the standard fixative. Formalin penetrates tissue at a rate of approximately 1 mm per hour. For large samples, slice to 1 to 2 cm thickness to ensure proper fixation.

For electron microscopy, use glutaraldehyde-based fixatives. For immunohistochemistry, use formalin or specialized fixatives depending on the antigen.

For molecular testing, avoid formalin-fixed tissues. Use fresh or frozen samples for PCR and sequencing.

Transport Media

For swabs and small tissue samples, use transport media to maintain viability of pathogens. Viral transport media contains antibiotics, antifungal agents, and protein stabilizers. Bacterial transport media, such as Cary-Blair or Amies, maintain bacterial viability without allowing overgrowth.

Prepare transport media according to manufacturer instructions. Store at 4°C and use within expiration date. Do not freeze transport media unless specified.

Labeling and Documentation

Every sample must be labeled with a unique identifier that links to the animal's record. Include species, sample type, collection date, collector initials, and any relevant clinical information.

Use waterproof labels or markers. Place labels on the container, not the lid. For frozen samples, use labels that withstand freezing.

Maintain a sample log with the following information: animal ID, species, location, date, time, sample type, preservation method, test requested, and results. This log is essential for tracking samples and interpreting results.

Shipping Requirements for Wildlife Samples

Packaging

Samples must be packaged according to international regulations for transport of biological substances. Use a triple packaging system: primary container (tube or vial), secondary container (leak-proof bag or container), and outer packaging (rigid box or cooler).

For infectious substances, follow International Air Transport Association (IATA) regulations. For non-infectious samples, follow Category B (UN 3373) requirements.

Place absorbent material between primary and secondary containers. Use ice packs or dry ice for temperature control. For dry ice, ensure proper ventilation and labeling.

Documentation

Include a detailed packing list with sample information, test requests, and contact information. Include a Material Safety Data Sheet if shipping hazardous substances.

For international shipments, obtain necessary permits and health certificates. Check import requirements for the destination country.

Courier Selection

Use a courier experienced in shipping biological samples. Provide clear instructions for handling and temperature control. Track shipments and confirm delivery.

For time-sensitive samples, use overnight shipping. For samples requiring dry ice, confirm the courier accepts dry ice shipments.

Laboratory Tests for Wildlife Pathogens

Polymerase Chain Reaction (PCR)

PCR detects pathogen DNA or RNA in samples. It is highly sensitive and specific, making it useful for detecting low levels of pathogen or when culture is difficult.

Real-time PCR (qPCR) provides quantitative results and is commonly used for viral and bacterial detection. Conventional PCR is used for pathogen identification and sequencing.

Sample types for PCR include blood, swabs, tissues, feces, and urine. For RNA viruses, use RNA-stabilizing reagents or freeze samples immediately at -80°C.

PCR can detect pathogens that are non-viable or difficult to culture. However, it cannot distinguish between live and dead organisms. Positive results should be interpreted in context with clinical signs and other tests.

Serology

Serology detects antibodies or antigens in serum, plasma, or whole blood. Common serological tests include enzyme-linked immunosorbent assay (ELISA), virus neutralization, hemagglutination inhibition, and indirect fluorescent antibody tests.

Serology is used to detect past or current infection, monitor vaccine response, and survey populations for pathogen exposure. It is particularly useful for diseases where pathogen detection is difficult, such as chronic or latent infections.

Interpret serology results with caution. Antibodies may persist after infection has resolved. Cross-reactivity with related pathogens can cause false positives. Negative results do not rule out infection if samples are collected before seroconversion.

Paired serology (acute and convalescent samples) is more informative than single samples. Collect acute samples at the time of clinical signs and convalescent samples 2 to 4 weeks later.

Bacterial Culture

Bacterial culture isolates and identifies bacteria from samples. It is essential for determining antimicrobial susceptibility and characterizing bacterial strains.

Sample types for culture include swabs, tissues, feces, urine, and blood. Collect samples aseptically to avoid contamination. Use transport media to maintain bacterial viability.

Culture results depend on the bacteria present, sample quality, and culture conditions. Some bacteria are fastidious and require special media or incubation conditions. Anaerobic bacteria require oxygen-free conditions.

Report culture results with bacterial identification and antimicrobial susceptibility patterns. Interpret results in context with clinical signs and other laboratory findings.

Fungal Culture

Fungal culture isolates and identifies fungi from samples. It is used for diagnosing fungal infections such as aspergillosis, candidiasis, and dermatophytosis.

Sample types for fungal culture include swabs, tissues, hair, feathers, and skin scrapings. Use sterile collection techniques and transport media.

Fungal culture may take days to weeks due to slow growth. Some fungi require special media or incubation conditions. Interpret results with caution, as some fungi are environmental contaminants.

Histopathology

Histopathology examines tissue sections under a microscope to identify lesions and pathogens. It is essential for diagnosing diseases that cause tissue damage.

Tissues are fixed in formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E). Special stains can identify specific pathogens or tissue components.

Histopathology can identify inflammation, necrosis, neoplasia, and other pathological changes. It can also detect pathogens such as bacteria, fungi, parasites, and viral inclusions.

Interpret histopathology results in context with gross findings, clinical signs, and other laboratory tests. Some lesions are non-specific and require additional testing for definitive diagnosis.

Immunohistochemistry

Immunohistochemistry (IHC) uses antibodies to detect specific antigens in tissue sections. It is used to identify pathogens, characterize cell types, and diagnose diseases.

IHC is performed on formalin-fixed, paraffin-embedded tissues. It requires specific antibodies validated for the species and pathogen of interest.

IHC can detect pathogens that are difficult to culture or identify by histopathology. It can also localize pathogens to specific tissues or cell types.

Interpret IHC results with positive and negative controls. Non-specific staining can occur, especially in tissues with high background.

Electron Microscopy

Electron microscopy (EM) examines samples at high magnification to identify viruses and other small pathogens. It is used for diagnosing viral infections when other tests are unavailable or inconclusive.

Sample types for EM include tissues, feces, and viral culture supernatants. Samples must be fixed in glutaraldehyde or other EM fixatives.

EM can identify virus morphology and size, which can guide pathogen identification. However, it requires specialized equipment and expertise.

CRISPR-Based Detection

CRISPR-Cas systems are emerging as rapid, sensitive tools for detecting wildlife pathogens. These methods can detect nucleic acids from viruses, bacteria, and parasites in field settings.

CRISPR-based detection offers advantages in speed, portability, and cost compared to traditional PCR. It can be performed with minimal equipment and training.

However, CRISPR-based methods are still under development for many wildlife pathogens. Validation and standardization are needed before widespread use.

Common Wildlife Pathogens and Diagnostic Approaches

Viral Pathogens

Rabies virus is diagnosed by direct fluorescent antibody test on brain tissue, PCR, or virus isolation. Collect brain samples (hippocampus, brainstem, cerebellum) from suspect animals. Use biosafety level 2 or 3 precautions.

Avian influenza virus is diagnosed by PCR, virus isolation, or serology. Collect swabs (tracheal, cloacal) and tissues (lung, trachea). Report positive results to animal health authorities.

West Nile virus is diagnosed by PCR, serology (IgM capture ELISA), or virus isolation. Collect blood, swabs (oral, cloacal), and tissues (brain, heart, kidney).

Canine distemper virus is diagnosed by PCR, immunohistochemistry, or serology. Collect swabs (nasal, conjunctival), blood, and tissues (lung, brain, bladder).

Bacterial Pathogens

Mycobacterium bovis is diagnosed by bacterial culture, PCR, or interferon-gamma release assay. Collect tissues (lymph nodes, lung) and swabs (nasal, bronchial). Culture requires 6 to 8 weeks due to slow growth.

Brucella species are diagnosed by bacterial culture, PCR, or serology (Rose Bengal test, complement fixation). Collect blood, tissues (spleen, lymph nodes, reproductive tract), and swabs (vaginal, preputial).

Francisella tularensis is diagnosed by PCR, bacterial culture, or serology. Collect blood, swabs (ulcer, lymph node), and tissues (spleen, liver). Use biosafety level 2 precautions.

Leptospira species are diagnosed by PCR, bacterial culture, or serology (microscopic agglutination test). Collect blood, urine, and tissues (kidney, liver).

Fungal Pathogens

Aspergillus species are diagnosed by fungal culture, PCR, or histopathology. Collect swabs (air sac, trachea), tissues (lung, air sac), and blood for serology.

Candida species are diagnosed by fungal culture or histopathology. Collect swabs (oral, crop, cloaca) and tissues.

Dermatophytes are diagnosed by fungal culture or histopathology. Collect hair, feathers, and skin scrapings.

Parasitic Pathogens

Toxoplasma gondii is diagnosed by PCR, serology, or histopathology. Collect blood, tissues (brain, muscle), and feces.

Sarcocystis species are diagnosed by histopathology, PCR, or fecal examination. Collect tissues (muscle, brain) and feces.

Trichinella species are diagnosed by muscle biopsy, PCR, or serology. Collect muscle samples (diaphragm, tongue, masseter).

Necropsy Procedures for Wildlife Disease Diagnostics

Preparation

Necropsy should be performed as soon as possible after death to minimize autolysis. For carcasses in poor condition, prioritize sample collection for PCR and culture over histopathology.

Use personal protective equipment (PPE) including gloves, mask, eye protection, and waterproof apron. For zoonotic pathogens, use additional precautions such as N95 respirators and face shields.

Set up a clean work area with adequate lighting, ventilation, and drainage. Have all equipment ready: scalpel blades, forceps, scissors, bone cutters, syringes, needles, culture swabs, transport media, formalin containers, and labels.

External Examination

Record species, sex, age, weight, and body condition. Note any external lesions, wounds, ectoparasites, or abnormalities. Collect swabs from external lesions if present.

Photograph the carcass from multiple angles. Document any identifying marks, tags, or collars.

Internal Examination

Open the carcass using a midline incision from the mandible to the pubis. Reflect the skin and examine subcutaneous tissues.

Open the body cavity and examine organs in situ. Note any fluid accumulations, adhesions, or abnormalities.

Remove organs systematically: first the gastrointestinal tract, then the liver, spleen, pancreas, kidneys, adrenal glands, reproductive tract, and urinary bladder. Then remove the thoracic organs: heart, lungs, and trachea.

For the head, remove the brain by sawing through the skull. For birds, remove the brain through the foramen magnum.

Sample Collection During Necropsy

Collect samples from all major organs and any lesions. For each organ, collect both fresh and fixed samples.

For fresh samples, place 1 to 2 cm³ pieces in sterile containers. For PCR, freeze at -20°C or -80°C. For bacterial culture, refrigerate and transport within 24 hours.

For fixed samples, place 1 to 2 cm³ pieces in 10% neutral buffered formalin. Ensure adequate fixation time (24 to 48 hours for small samples, longer for large samples).

Collect swabs from organs and lesions for culture and PCR. Use sterile swabs and transport media.

Carcass Decomposition Assessment

Carcass decomposition affects sample quality and diagnostic value. Decomposition stages include fresh, bloated, active decay, advanced decay, and dry remains.

For fresh carcasses (less than 24 hours post-mortem), all sample types are suitable. For bloated carcasses (24 to 72 hours), bacterial culture and PCR may still be useful, but histopathology is compromised. For actively decaying carcasses (3 to 10 days), PCR may detect pathogen DNA, but culture and histopathology are unreliable.

Estimate time of death based on decomposition stage, body temperature, and environmental conditions. Record these observations for interpretation of results.

Quality Control and Biosafety

Sample Quality Assessment

Assess sample quality before testing. Blood samples should be free of hemolysis, lipemia, and clots. Swabs should have adequate cellular material. Tissues should be free of autolysis and contamination.

Reject samples that are improperly labeled, contaminated, or degraded. Request new samples if possible.

Biosafety Precautions

Wildlife samples may contain zoonotic pathogens. Use standard precautions for all samples: gloves, lab coat, eye protection, and hand washing.

For samples from animals with suspected zoonotic diseases (rabies, tularemia, plague, hantavirus), use enhanced precautions: N95 respirator, face shield, double gloves, and waterproof gown.

Work in a biosafety cabinet for procedures that generate aerosols, such as grinding tissues or vortexing samples.

Decontaminate work surfaces with 10% bleach or other appropriate disinfectant. Dispose of waste according to institutional and regulatory requirements.

Laboratory Quality Assurance

Use validated assays when available. For wildlife species, assays may need to be validated for the target species.

Include positive and negative controls in each test run. Monitor control results for trends that indicate assay drift.

Participate in proficiency testing programs when available. Document all quality control results.

Common Failure Patterns in Wildlife Disease Diagnostics

Sample Degradation

Sample degradation is a common cause of failed testing. Degradation can occur due to delayed collection, improper storage, or freeze-thaw cycles.

To prevent degradation, collect samples as soon as possible after death or clinical signs. Keep samples cool during transport. Freeze samples at appropriate temperatures. Avoid repeated freeze-thaw cycles.

Contamination

Contamination can occur during collection, processing, or testing. Contaminated samples may produce false positive or false negative results.

To prevent contamination, use sterile equipment and aseptic technique. Work in a clean environment. Use separate equipment for each sample.

Insufficient Sample Volume

Insufficient sample volume can prevent testing or reduce sensitivity. For blood samples, collect adequate volume for the tests requested. For tissues, collect samples of appropriate size.

For small animals, prioritize tests based on clinical suspicion. Collect multiple sample types to increase diagnostic yield.

Improper Labeling

Improper labeling can lead to sample mix-ups and incorrect results. Label all containers immediately after collection. Use unique identifiers that link to the animal's record.

Double-check labels before shipping. Include a packing list with sample information.

Inappropriate Test Selection

Selecting the wrong test can lead to false negative results. Consider the pathogen suspected, sample type, and test sensitivity and specificity.

Consult with the diagnostic laboratory for test recommendations. Provide clinical history and suspected pathogens.

Limitations of Wildlife Disease Diagnostics

Species-Specific Assays

Many diagnostic assays are developed for domestic animals and may not be validated for wildlife species. Cross-reactivity, sensitivity, and specificity may differ.

Use assays validated for the target species when available. For unvalidated assays, interpret results with caution and confirm with alternative methods.

Sample Quality

Sample quality is often compromised in wildlife due to delayed collection, environmental exposure, or autolysis. Degraded samples may produce false negative results.

Prioritize sample collection as soon as possible after death. Use appropriate preservation methods. Document sample quality for interpretation.

Pathogen Detection Limits

All diagnostic tests have detection limits. Low pathogen loads may not be detected, especially in early infection or chronic carriers.

Use sensitive assays such as PCR for low-level detection. Collect multiple sample types to increase detection probability.

Interpretation Challenges

Interpreting diagnostic results requires consideration of clinical signs, epidemiology, and other laboratory findings. Positive results may indicate infection, contamination, or cross-reactivity. Negative results may indicate absence of pathogen, low pathogen load, or sample degradation.

Consult with a veterinary pathologist or diagnostic specialist for complex cases. Report results to wildlife health authorities for surveillance purposes.

Professional Escalation Criteria

Urgent Escalation

Contact a veterinary pathologist or diagnostic specialist immediately if:

• A zoonotic pathogen is suspected (rabies, tularemia, plague, hantavirus)
• A notifiable disease is suspected (avian influenza, rabies, anthrax, bovine tuberculosis)
• A die-off or unusual mortality event is observed
• A novel pathogen is suspected
• Results are inconsistent with clinical signs or epidemiology

Routine Escalation

Consult with a diagnostic laboratory or wildlife health specialist for:

• Test selection and interpretation
• Sample collection and preservation guidance
• Results that require confirmation
• Cases with complex or unusual findings

Reporting Requirements

Report notifiable diseases to animal health authorities as required by local, national, and international regulations. For wildlife, reporting may be to wildlife agencies, veterinary authorities, or the World Organisation for Animal Health (WOAH).

Document all findings and results for surveillance databases. Share data with other researchers and wildlife health networks.

Decision Framework for Selecting Diagnostic Tests in Wildlife Cases

Selecting the appropriate diagnostic test for wildlife samples requires a structured approach that balances clinical suspicion, sample quality, laboratory capacity, and resource constraints. Wildlife veterinarians and field biologists often face decisions under time pressure with limited sample volumes. A systematic decision framework helps avoid common errors such as testing the wrong sample type, selecting an insensitive assay, or misinterpreting results due to species-specific limitations.

Step 1: Define the Diagnostic Objective

Before selecting any test, clarify the primary question. Four common objectives guide test selection:

Objective A: Confirm clinical suspicion in a sick or dead animal. When clinical signs or necropsy findings suggest a specific pathogen, select a direct detection method such as PCR or culture. For example, if a raptor presents with neurological signs and rabies is suspected, direct fluorescent antibody testing on brain tissue is the appropriate first-line test. If avian influenza is suspected in waterfowl with respiratory signs, PCR on tracheal and cloacal swabs is indicated.

Objective B: Screen a population for exposure to a pathogen. For surveillance or outbreak investigations, serology is often the most practical approach. Serology detects antibodies indicating past or current exposure, which is useful for understanding pathogen circulation in a population. However, serology cannot confirm active infection or distinguish between vaccinated and naturally infected animals.

Objective C: Identify an unknown cause of disease or mortality. When the etiology is unclear, a broad diagnostic approach is needed. Collect multiple sample types and request a panel of tests including histopathology, PCR for common pathogens, bacterial culture, and toxicology. Histopathology is particularly valuable for identifying lesions that guide further testing.

Objective D: Confirm freedom from infection for translocation or reintroduction. For animals being moved between populations, a combination of direct detection (PCR or culture) and serology is often required. The specific tests depend on the pathogens of concern for the source and destination populations.

Step 2: Assess Sample Quality and Suitability

Sample quality directly determines which tests can produce reliable results. Use the following criteria to evaluate samples before selecting tests:

Blood samples: Assess for hemolysis, lipemia, and clotting. Hemolyzed serum is unsuitable for some serological tests and may produce false positive or false negative results. Clotted blood cannot be used for hematology or flow cytometry. For PCR, EDTA whole blood is preferred, heparin can inhibit PCR in some assays.

Swab samples: Evaluate for adequate cellular material. A swab that appears dry or contains only mucus may have insufficient cells for PCR or culture. Swabs should be visibly moist with cellular material after collection.

Tissue samples: Assess for autolysis, contamination, and fixation quality. Fresh tissues for PCR should be free of visible decomposition. Formalin-fixed tissues should be properly penetrated, large tissue pieces may have central autolysis despite adequate fixation time.

Fecal samples: Evaluate for freshness and absence of environmental contamination. Old or dried feces may have degraded DNA or RNA, reducing PCR sensitivity. Contamination with soil or water can introduce inhibitors.

Document sample quality on the submission form. If sample quality is poor, note this limitation in the interpretation of results. For degraded samples, PCR may still detect pathogen DNA but culture and histopathology are unlikely to yield useful results.

Step 3: Match Test to Pathogen and Sample Type

Different pathogens require different detection methods and sample types. The table below provides a decision matrix for common wildlife pathogens.

Step 4: Consider Test Limitations and Interpretation Challenges

Every diagnostic test has limitations that affect interpretation. The following common pitfalls should be considered before finalizing test selection.

PCR detects nucleic acid, not viable organisms. A positive PCR result may indicate active infection, recent infection with residual nucleic acid, or contamination. PCR cannot distinguish between live and dead organisms. For bacteria, a positive PCR does not confirm viability or antimicrobial susceptibility.

Serology detects antibodies, not active infection. Antibodies may persist for months or years after infection has resolved. A positive serology result indicates exposure but not necessarily current infection. Paired serology (acute and convalescent samples) is more informative than single samples.

Culture requires viable organisms. Samples that have been frozen, exposed to high temperatures, or collected from decomposed carcasses may not yield viable organisms for culture. Culture-negative results do not rule out infection if sample quality is compromised.

Histopathology identifies lesions but not always the cause. Many pathogens produce non-specific lesions that require additional testing for definitive diagnosis. Histopathology is most useful when combined with other tests such as immunohistochemistry or PCR.

Species-specific validation is often lacking. Many commercial assays are developed for domestic animals and may not perform identically in wildlife species. Cross-reactivity, sensitivity, and specificity may differ. When using unvalidated assays, interpret results with caution and confirm with alternative methods when possible.

Step 5: Prioritize Tests When Sample Volume Is Limited

Wildlife samples are often limited in volume, especially from small species or carcasses in poor condition. When sample volume is insufficient for all desired tests, prioritize based on the diagnostic objective and sample quality.

Priority 1: Direct detection methods (PCR or culture) for the most likely pathogen. If clinical signs or epidemiology suggest a specific pathogen, test for that pathogen first. PCR is often preferred because it requires small sample volumes and can detect non-viable organisms.

Priority 2: Histopathology for unknown causes. If the etiology is unclear, histopathology provides the most information from a single sample. Fixed tissues can be stored and used for additional testing later.

Priority 3: Serology for population screening. Serology requires serum or plasma, which may be limited in small animals. If serology is the primary objective, collect blood first and prioritize serum separation.

Priority 4: Archival samples for future testing. If sample volume is insufficient for all desired tests, freeze or fix samples for future testing. Document what tests were not performed and why.

Step 6: Document the Decision Process

Record the rationale for test selection in the animal's medical record or sample log. Include the following information:

• Diagnostic objective (confirm clinical suspicion, screen population, identify unknown cause, confirm freedom from infection)
• Sample quality assessment (adequate, compromised, degraded)
• Tests selected and rationale
• Tests not selected and rationale
• Limitations noted for interpretation

This documentation is essential for interpreting results, especially if results are unexpected or inconsistent with clinical signs. It also provides a record for quality improvement and future reference.

Common Failure Patterns in Test Selection

Failure Pattern 1: Testing the wrong sample type. For example, using serum for PCR when whole blood is required, or using formalin-fixed tissues for culture when fresh tissues are needed. Always verify the required sample type with the diagnostic laboratory before collection.

Failure Pattern 2: Selecting an insensitive test for the pathogen load. For early infections or chronic carriers with low pathogen loads, PCR is more sensitive than culture or antigen detection. If clinical suspicion is high but initial tests are negative, consider retesting with a more sensitive method.

Failure Pattern 3: Relying on a single test for diagnosis. No single test is 100% sensitive and specific. Combining multiple tests (e.g., PCR and serology, or PCR and culture) increases diagnostic confidence. For notifiable diseases, confirm positive results with a second test method.

Failure Pattern 4: Ignoring sample quality limitations. Testing degraded samples wastes resources and may produce misleading results. If sample quality is poor, document the limitation and interpret results with caution. Consider requesting new samples if possible.

Failure Pattern 5: Overinterpreting unvalidated assays. Using assays developed for domestic animals in wildlife species without validation can lead to false positive or false negative results. When validation data are lacking, report results as presumptive and confirm with alternative methods.

Professional Escalation Criteria for Test Selection

Urgent escalation: Contact a veterinary pathologist or diagnostic specialist immediately if:

• A notifiable or zoonotic pathogen is suspected and test selection is uncertain
• A novel pathogen is suspected and no validated test exists
• A die-off or unusual mortality event requires rapid diagnostic response
• Test results are inconsistent with clinical signs or epidemiology

Routine escalation: Consult with a diagnostic laboratory or wildlife health specialist for:

• Guidance on test selection for uncommon pathogens or species
• Interpretation of results from unvalidated assays
• Recommendations for confirmatory testing
• Assistance with sample collection and preservation for specialized tests

Records and Measurements for Test Selection Decisions

Maintain a log of test selection decisions for each case. Include the following fields:

• Case number and animal identification
• Species and age
• Clinical signs and necropsy findings
• Diagnostic objective
• Sample types collected and quality assessment
• Tests requested and rationale
• Laboratory used and contact information
• Results and interpretation
• Limitations noted
• Follow-up actions taken

This log serves as a reference for future cases and supports quality improvement efforts. Review patterns of test selection and outcomes periodically to identify opportunities for improvement.

Welfare and Safety Context

Test selection directly affects animal welfare and human safety. For live animals, minimize handling stress and sample collection time. Use appropriate restraint and anesthesia when necessary. For carcasses, prioritize sample collection for zoonotic pathogens to protect personnel and the public.

For zoonotic pathogens such as rabies, tularemia, and hantavirus, select tests that can be performed safely on inactivated samples when possible. PCR can detect nucleic acid from inactivated samples, reducing biosafety risk. Culture and virus isolation require viable organisms and higher biosafety levels.

For notifiable diseases, select tests that provide definitive diagnosis for reporting purposes. Confirm positive results with a second test method before reporting to animal health authorities. Follow local, national, and international reporting requirements as outlined by the World Organisation for Animal Health (WOAH).

Practical Implementation Steps

1. Define the diagnostic objective before collecting samples.
2. Assess sample quality immediately after collection.
3. Match the test to the pathogen and sample type using the decision matrix.
4. Consider test limitations and interpretation challenges.
5. Prioritize tests when sample volume is limited.
6. Document the decision process for future reference.
7. Escalate to a specialist when results are unexpected or a novel pathogen is suspected.
8. Review test selection patterns periodically for quality improvement.

This decision framework provides a structured approach to test selection that improves diagnostic accuracy, reduces waste of limited samples, and supports wildlife health management decisions. By following these steps, wildlife veterinarians and field biologists can maximize the diagnostic value of each sample and contribute to effective disease surveillance and response.

Frequently Asked Questions

What is the best sample type for detecting viral pathogens in wildlife?

The best sample type depends on the virus and the stage of infection. For respiratory viruses, nasal and oral swabs are preferred. For systemic viruses, blood and tissues (spleen, liver, lung) are useful. For neurotropic viruses, brain tissue is essential. Collect multiple sample types to increase detection probability.

How should I store and transport wildlife samples for PCR testing?

For PCR testing, freeze samples at -20°C or -80°C as soon as possible after collection. For RNA viruses, use RNA-stabilizing reagents or freeze at -80°C. Transport samples on dry ice. Avoid freeze-thaw cycles. Use sterile containers and label clearly.

Can I use the same diagnostic tests for wildlife as for domestic animals?

Many diagnostic tests developed for domestic animals can be used for wildlife, but validation is important. Cross-reactivity, sensitivity, and specificity may differ. Consult with the diagnostic laboratory for test recommendations. Use species-specific assays when available.

How do I collect blood samples from a dead wildlife carcass?

Blood can be collected from the heart, major vessels, or body cavity within hours of death. Use a sterile needle and syringe. Collect blood into appropriate tubes. Blood from carcasses may be hemolyzed or contaminated, limiting its use for some tests. Document sample quality.

What should I do if I suspect a zoonotic pathogen in a wildlife sample?

Use enhanced biosafety precautions: N95 respirator, face shield, double gloves, and waterproof gown. Work in a biosafety cabinet if available. Contact the diagnostic laboratory for guidance on sample handling and testing. Report suspected zoonotic pathogens to public health authorities.

How long can I store formalin-fixed tissues before processing?

Formalin-fixed tissues can be stored at room temperature for months to years. However, prolonged storage may degrade antigens for immunohistochemistry. Process tissues within 2 to 4 weeks for optimal results. For long-term storage, transfer tissues to 70% ethanol after fixation.

What is the difference between PCR and serology for wildlife disease diagnostics?

PCR detects pathogen DNA or RNA, indicating current or recent infection. Serology detects antibodies, indicating past or current infection. PCR is useful for early detection and confirmation of active infection. Serology is useful for surveillance and determining population exposure. Both tests have limitations and should be interpreted in context.

How do I interpret negative PCR results in a wildlife sample?

Negative PCR results may indicate absence of the target pathogen, low pathogen load below detection limits, sample degradation, or inhibition of the PCR reaction. Consider sample quality, timing of collection, and clinical signs. If clinical suspicion is high, repeat testing with a different sample type or test method.

Related Veterinary Guides

• History Of Diseases
• Biotech Clinical Laboratories
• Laboratory Protocol Sections Version Control Deviations
• Backyard Duck Health Common Diseases Preventive Care
• Rabbit Disease Observation Logs And Veterinary Escalation

References and Further Reading

• olaw.nih.gov
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Impediments to wildlife disease surveillance, research, and diagnostics.. Current topics in microbiology and immunology, 2007.
• Shifting from wildlife disease threats to wildlife health.. Revue scientifique et technique (International Office of Epizootics), 2024.
• Rinderpest.. The Veterinary clinics of North America. Food animal practice, 2002.
• Editorial: Health and Disease in Free-Ranging and Captive Wildlife.. Frontiers in veterinary science, 2020.
• Pathology in Practice.. Journal of the American Veterinary Medical Association, 2022.
• Early Detection of Wildlife Disease Pathogens Using CRISPR-Cas System Methods.. The CRISPR journal, 2024.
• Protocol to classify the stages of carcass decomposition and estimate the time of death in small-size raptors. European Journal of Wildlife Research, 2020.
• Wildfire-related lesions in a free-ranging Paraguayan Hairy Dwarf Porcupine (Coendou spinosus) in Brazil. Brazilian Journal of Veterinary Pathology, 2026.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.